Showing results (61-70 of 940) with videos related to

Sort By:
Pageof 94
Thrombosis and Haemostasis|September 9, 2011
Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumoniaMarcel Schouten, Cornelis van 't Veer, Joris J T H Roelofs, et al.
Shock (Augusta, Ga.)|December 23, 2004
Endogenous interleukin-12 improves the early antimicrobial host response to murine Escherichia coli peritonitisSebastiaan Weijer, Sandrine Florquin, Tom van der Poll
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemiaRosemarijn Renckens, Sebastiaan Weijer, Alex F de Vos, et al.
Critical Care Medicine|November 3, 2006
Salmeterol enhances pulmonary fibrinolysis in healthy volunteersNico A Maris, Alex F de Vos, Paul Bresser, et al.
Critical Care Medicine|May 9, 2012
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*Liesbeth M Kager, W Joost Wiersinga, Joris J T H Roelofs, et al.
American Journal of Respiratory Cell and Molecular Biology|April 19, 2008
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulationIda A J Giebelen, Masja Leendertse, Mark C Dessing, et al.
Scandinavian Journal of Infectious Diseases|June 19, 2002
Diabetes insipidus as a complication of cryptococcal meningitis in an HIV-infected patientNicole P Juffermans, Annelies Verbon, Tom Van der Poll
Critical Care (London, England)|February 8, 2008
Targeting RAGE in sepsisMarieke A D van Zoelen, Tom van der Poll
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin BRosemarijn Renckens, Jennie M Pater, Tom van der Poll
Pageof 94